Abiomed Inc.
ABMD
Market Cap$0
Close$
$383.91
0.8% upside
Current Fair Value
0.8% upsideUndervalued by 0.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-820,372,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $5.8 |
| Beta | 0.0 |
| Outstanding Shares | 45,091,184 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | 16.57 |
| Price to Book Ratio | 11.21 |
| Enterprise Value to Revenue | -0.76 |
| Enterprise Value to EBIT | -3.23 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Abiomed Inc.
1,371 employees
CEO: Michael Minogue Abiomed is a publicly-traded medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump. The company is headquartered in Danvers, Massachusetts and has three additional ...